Skip to content

Clinical trials

Phase 4 Hypertension trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20034
20043
20052
20062
20082
20091
20111
20122
20131
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Hamilton Health Sciences Corporation2
University of Alberta2
University of Western Ontario, Canada2
Abbott Medical Devices1
Bristol-Myers Squibb1
Institut de Recherches Cliniques de Montreal1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Montreal Heart Institute1
Mount Sinai Hospital, Canada1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension24
Cardiovascular Diseases3
Diabetes Mellitus, Type 23
Diabetes Mellitus2
Heart Failure2
Myocardial Infarction2
Stroke2
Acute Coronary Syndrome1
Albuminuria1
Anemia1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.